Holen Sie sich die Stockscreener-App
6.94
0.43%
-0.03
Handel nachbörslich:
6.95
0.010
+0.14%
Schlusskurs vom Vortag:
$6.97
Offen:
$7.01
24-Stunden-Volumen:
235.08K
Relative Volume:
0.89
Marktkapitalisierung:
$151.71M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-7.383
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
+2.36%
1M Leistung:
-4.01%
6M Leistung:
+71.78%
1J Leistung:
+261.46%
1-Tages-Spanne:
$6.81
$7.10
1-Wochen-Bereich:
$6.7525
$7.308
52-Wochen-Spanne:
$1.78
$7.95
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
6.94 | 148.21M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Is Exagen Inc. a good long term investmentGame-changing capital returns - Autocar Professional
What analysts say about Exagen Inc. stockAccelerated financial growth - jammulinksnews.com
Exagen Inc. Stock Analysis and ForecastJaw-dropping returns - jammulinksnews.com
What drives Exagen Inc. stock priceHigh-yield growth strategies - jammulinksnews.com
Why Exagen Inc. stock attracts strong analyst attentionFree Stock Market Beginners Guide - Newser
Exagen Appoints Chas McKhann to Board of Directors - The Globe and Mail
Exagen Inc. Appoints Chas McKhann to Board of Directors - AInvest
Exagen Inc. Appoints Chas McKhann to Board of Directors | XGN St - GuruFocus
Exagen appoints Chas McKhann to board of directors By Investing.com - Investing.com Nigeria
Exagen appoints Chas McKhann to board of directors - Investing.com Australia
Exagen Strengthens Board with Healthcare Veteran Behind Two Boston Scientific Acquisitions - Stock Titan
Michael Mahler Joins Exagen as Chief Scientific Officer - Medical Product Outsourcing
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
What makes Exagen Inc. stock price move sharplyFree Expert Investment Advice - Newser
How Exagen Inc. stock performs during market volatilityFree Risk Assessment Services - Newser
Exagen Inc. Announces Second Quarter 2025 Financial Results Release Date - AInvest
Exagen Inc. to Announce Q2 2025 Financial Results and Host Conference Call on July 29 - Nasdaq
Exagen Schedules Q2 2025 Earnings: CEO and CFO to Present Before Market Opens July 29 - Stock Titan
Exagen Inc.(NasdaqGM: XGN) added to Russell 3000E Index - MarketScreener
Exagen Inc.(NasdaqGM: XGN) added to Russell Microcap Growth Index - MarketScreener
Exagen Insider Ups Holding During Year - Yahoo.co
Exagen Inc. (XGN): Insider Confidence and Undervaluation Signal Buying Opportunity Ahead of Key Earnings - AInvest
Exagen announces resale of up to 1.15M shares - MSN
Exagen appoints Michael Mahler as CSO - TipRanks
Exagen appoints Dr. Michael Mahler as chief scientific officer - Investing.com
Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World
Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World
Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st
Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World
Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):